Phase 1 Birth Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Pharmacokinetics and Placental Transfer of Caffeine

Apnea of PrematurityPremature BirthBronchopulmonary Dysplasia+2 more

Indiana University30 enrolled1 locationNCT07570121

Recruiting

Phase 1Phase 2

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births

Duke University28 enrolled5 locationsNCT07101640

Recruiting

Phase 1Phase 2

Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

PreeclampsiaPreterm Birth

Thomas Jefferson University400 enrolled1 locationNCT06826859

Recruiting

Phase 1

Human Amnion Epithelial Cells for Prevention of Bronchopulmonary Dysplasia in Preterm Infants: A Safety Study

Bronchopulmonary DysplasiaExtremely preterm birth

Monash Health24 enrolled2 locationsACTRN12618000920291